NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)

被引：0
|
作者：
Cavina, Raffaele
Gregorc, Vanesa
Novello, Silvia
Grossi, Francesco
Santoro, Armando
Vigano, Maria Grazia
Levra, Matteo G.
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Humanitas Canc Ctr, Rozzano, Italy
[2] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[3] Univ Turin, Thorac Oncol Unit, AUO San Luigi, Orbassano, Italy
[4] Natl Canc Res Ctr, Lung Canc Unit, Genoa, Italy
[5] Humanitas Canc Ctr, Dept Oncol, Rozzano, Italy
[6] MolMed, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7085
引用
收藏
页数：1
相关论文
共 50 条
  • [1] NGR-HTNF IN COMBINATION WITH DOXORUBICIN IN RELAPSED SMALL-CELL LUNG CANCER (SCLC)
    Gregorc, V.
    Santoro, A.
    Novello, S.
    Grossi, F.
    Levra, M. Giaj
    Cavina, R.
    Vigano, M. G.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 149 - 150
  • [2] NGR-HTNF PLUS DOXORUBICIN IN RELAPSED SMALL CELL LUNG CANCER (SCLC)
    Novello, Silvia
    Cavina, Raffaele
    Vigano, Maria G.
    Grossi, Francesco
    Santoro, Armando
    Gregorc, Vanesa
    Scagliotti, Giorgio
    Garassino, Isabella
    Rossoni, Gilda
    Levra, Matteo G.
    Genova, Carlo
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1348 - S1349
  • [3] Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC)
    Vigano, M. G.
    Cavina, R.
    Novello, S.
    Grossi, F.
    Santoro, A.
    Gregorc, V.
    Scagliotti, G.
    Garassino, I. M.
    Rossoni, G.
    Levra, M. G.
    Genova, C.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Phase II Trial of NGR-hTNF and Doxorubicin in Relapsed Small Cell Lung Cancer (SCLC)
    Vigano, M.
    Cavina, R.
    Novello, S.
    Grassi, F.
    Santoro, A.
    Gregorc, V.
    Rossoni, G.
    Levra, M. G.
    Lambiases, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S623 - S623
  • [5] Phase II study of NGR-hTNF, a vascular targeting agent, in combination with doxorubicin in patients with relapsed small cell lung cancer (SCLC)
    Gregorc, V.
    Novello, S.
    Santoro, A.
    Grossi, F.
    Levra, M. Giaj
    Cavina, R.
    Vigano, M.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] NGR-hTNF and doxorubicin in relapsed ovarian cancer (OC).
    Lorusso, Domenica
    Scambia, Giovanni
    Amadio, Giulia
    di Legge, Alessia
    Pietragalla, Antonella
    De Vincenzo, Rosa
    Masciullo, Valeria
    Di Stefano, Mirella
    Mangili, Giorgia
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer
    Gregorc, Vanesa
    Cavina, Raffaele
    Novello, Sivia
    Grossi, Francesco
    Lazzari, Chiara
    Capelletto, Enrica
    Genova, Carlo
    Salini, Giulia
    Lambiase, Antonio
    Santoro, Armando
    ONCOLOGIST, 2018, 23 (10): : 1133 - +
  • [8] Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
    Lorusso, D.
    Scambia, G.
    Amadio, G.
    di Legge, A.
    Pietragalla, A.
    De Vincenzo, R.
    Masciullo, V.
    Di Stefano, M.
    Mangili, G.
    Citterio, G.
    Mantori, M.
    Lambiase, A.
    Bordignon, C.
    BRITISH JOURNAL OF CANCER, 2012, 107 (01) : 37 - 42
  • [9] Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC)
    Lorusso, D.
    Scambia, G.
    Amadio, G.
    Trivellizzi, N.
    Pietragalla, A.
    De Vincenzo, R.
    Salutari, V.
    Di Stefano, M.
    Lambiase, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S536 - S536
  • [10] Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
    D Lorusso
    G Scambia
    G Amadio
    A di Legge
    A Pietragalla
    R De Vincenzo
    V Masciullo
    M Di Stefano
    G Mangili
    G Citterio
    M Mantori
    A Lambiase
    C Bordignon
    British Journal of Cancer, 2012, 107 : 37 - 42
12345